Table 1: Literature review of reported adult spinal AT/RT cases.

Reference

Age/Sex

Primary location

Immunostain+

Leptomeningeal spread

Primary treatment

Survival (months)

Bruch, et al., [8]

21 F

-

EMA, Vim, CK

-

-

6

Zarovnaya, et al., [9]

43 M

T11-L1

EMA

Y

UTR/Rad

30

Kanoto, et al., [10]

60 M

C5-T1

-

-

-

18

Gotti, et al., [11]

19 F

L4-L5

EMA, CAM, Vim, CD99

_

GTR/Rad/Chemo

> 36

Sinha, et al., [12]

65 M

T11-L1

EMA, CAM, Vim, PanCK

Y

STR/Rad

24

Li, et al., [13]

23 F

L2-L4

-

-

Rad/Chemo

12

McGinity, et al., [14]

43 F

C1-C3

EMA, SMA, Vim

N

GTR/Rad

> 6

Neromyliotis, et al., [15]

19 F

L4-S2

EMA, Vim, CK CD55

Y

STR/Rad

> 9

Sant, et al., [16]

20 M

C7-T2

EMA, CD99

-

STR/Rad/Chemo

-

Present Study

26 M

L4

EMA, SMA

Y

GTR/Rad/Chemo

12

Primary location: Location of primary lesion; Primary treatment: Treatment of primary lesion.
Treatment: GT: Gross total resection; STR: Sub-total resection; UTR: Resection unknown extent; Rad: Radiation. Immunostaining: CK: Cytokeratin; EMA: Epithelial membrane antigen; Vim: Vimentin; CAM: Cell adhesion molecule; PanC: Pancytokeratin; SMA: Smooth muscle antigen